We provide innovative medical propellants to the world’s biggest pharmaceutical companies. All of our products are produced to the most demanding industry standards at our dedicated facilities. Find out more about our global community.
Zephex® 152A will reduce the carbon footprint by 90% compared to current metered dose inhalers. Our low GWP medical propellant is a commitment to both end users and our environment.
From the Newsroom
The University of Manchester has announced Melissa Pace as the third student to receive Koura’s Alasdair Sinclair Scholarship.Read more
If you missed it at DDL, you can now view and download a copy of the poster we displayed at the conference last week.Read more